Robert Kratzke, MD, calls for a national biomarker testing mandate, emphasizing that timely genomic testing is essential for precision lung cancer care. In part 2 of an interview with The American ...

A comparison of eight AI-powered requirements management platforms for 2026, from NLP-based quality analysis and automated test generation to live traceability scoring, covering Jama Connect, IBM ...

Six leading test automation tools scored on a transparent, weighted rubric with the reasoning behind each score and how to ...

A private company advising the agency that oversees Medicare has recommended against reimbursing for the biomarker tests, ...

THOMAS TUCHEL faces the ultimate litmus test of his England tenure this Monday morning as the Three Lions march into the ...

Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered ...

Coverage is the real problem, not detection. The teams that will thrive over the next five years are the ones rebuilding ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

AI is generating code faster than humans can ever hope to verify. If your QA strategy hasn't evolved to match the speed of AI generation, your systems are living on borrowed time.

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more.

(NEXSTAR) – Cell providers all claim to have the best coverage, fastest speeds or most reliability in their ad campaigns. But who really comes out on top? Data released last month by the Federal ...